CD8A and neoplasm: Moreover, combinatorial treatment with peptide-based vaccines and immune checkpoint inhibitors was demonstrated to prolong the survival of tumor-bearing mice via enhanced vaccine-induced immune responses and tumor-infiltrating CD8+ T cell counts, leading to delayed tumor growth (16).